Form 4 holding
Chief R&D Officer
Axogen, Inc.
- Security class
- Common Stock
- Shares / value
- 57,994
- Estimated value
- $445,394
- Report date
- 21 Mar 2024
- Price
- $7.68
- Ownership
- Direct
Angelo Scopelianos
Insider Reports History
- Location
- Alachua, FL
- Owner filing signature
- /s/ Angelo Scopelianos
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
1 identity field
SEC source record
1 source field
Source evidence
1 source field
Reported holdings for Angelo Scopelianos
Form 4 holding
Chief R&D Officer
Axogen, Inc.
- Security class
- Restricted Stock Units
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 16 Mar 2024
- Price
- $7.68
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Angelo Scopelianos
4
AXGN
Axogen, Inc.
- Report period
- 16 Mar 2024
- Transactions
- 9
- Transaction value
- -$52,846
- Accepted by SEC
- 25 Mar 2024, 21:37
- Role
- Chief R&D Officer
- Next action
- Open filing details
4
AXGN
Axogen, Inc.
- Report period
- 18 Jul 2023
- Transactions
- 2
- Transaction value
- -$5,668
- Accepted by SEC
- 13 Oct 2023, 20:28
- Role
- Chief R&D Officer
- Next action
- Open filing details
4
AXGN
Axogen, Inc.
- Report period
- 16 Mar 2023
- Transactions
- 11
- Transaction value
- -$32,311
- Accepted by SEC
- 20 Mar 2023, 18:27
- Role
- Chief R&D Officer
- Next action
- Open filing details
4
AXGN
Axogen, Inc.
- Report period
- 27 Dec 2022
- Transactions
- 3
- Transaction value
- -$2,700
- Accepted by SEC
- 29 Dec 2022, 19:40
- Role
- Chief R&D Officer
- Next action
- Open filing details
4
AXGN
Axogen, Inc.
- Report period
- 18 Jul 2022
- Transactions
- 2
- Transaction value
- -$5,519
- Accepted by SEC
- 20 Jul 2022, 16:04
- Role
- Chief R&D Officer
- Next action
- Open filing details
4
AXGN
Axogen, Inc.
- Report period
- 16 Mar 2022
- Transactions
- 5
- Transaction value
- -$22,077
- Accepted by SEC
- 18 Mar 2022, 16:11
- Role
- Chief R&D Officer
- Next action
- Open filing details
4
AXGN
Axogen, Inc.
- Report period
- 15 Feb 2022
- Transactions
- 2
- Transaction value
- -$3,368
- Accepted by SEC
- 17 Feb 2022, 15:11
- Role
- Chief R&D Officer
- Next action
- Open filing details
4
AXGN
Axogen, Inc.
- Report period
- 27 Dec 2021
- Transactions
- 3
- Transaction value
- -$2,786
- Accepted by SEC
- 29 Dec 2021, 15:31
- Role
- Chief R&D Officer
- Next action
- Open filing details
4
AXGN
Axogen, Inc.
- Report period
- 19 Jul 2021
- Transactions
- 2
- Transaction value
- -$12,230
- Accepted by SEC
- 21 Jul 2021, 16:14
- Role
- Chief R&D Officer
- Next action
- Open filing details